Logotype for Innovative Industrial Properties Inc

Innovative Industrial Properties (IIPR) Investor presentation summary

Event summary combining transcript, slides, and related documents.

Logotype for Innovative Industrial Properties Inc

Investor presentation summary

3 Aug, 2026

Business overview and strategy

  • Operates as a diversified REIT with investments in cannabis and life sciences, holding 108 properties across 19 U.S. states and $2.4B in total invested capital as of June 2026.

  • Business model centers on long-term, triple-net leases, minimizing recurring capital expenditures and shifting revenue mix toward life sciences.

  • Strategic $270M investment in IQHQ expands exposure to life sciences, with fully funded commitments and rights to future asset sales.

  • Portfolio is diversified by geography, tenant, and property type, with 35+ tenants and a mix of industrial and retail assets.

  • Focus on serving two high-growth markets: cannabis (projected 8% CAGR through 2030) and life sciences, both benefiting from regulatory and innovation tailwinds.

Financial performance and capital structure

  • Q2 2026 total revenue reached $63.3M, with over $1.2B in dividends paid since inception and a 7% CAGR in AFFO/share from 2020 to Q2 2026.

  • Maintains a strong balance sheet with 1.7x net debt to adjusted EBITDA and $300M in available liquidity.

  • Raised $400M+ in exchangeable notes in June, with gross debt of $623.6M and common equity market capitalization of $1.7B.

  • Dividend per share grew at a 9% CAGR from 2020 to Q2 2026, and total return since inception is 486%, outperforming major indices.

  • AFFO and EBITDA reconciliations provided, highlighting adjustments for non-core and non-cash items.

Portfolio and market positioning

  • Top 10 states account for 89% of annualized base rent, with Illinois, Pennsylvania, and Massachusetts leading.

  • 90% of properties are industrial, primarily supporting regulated cannabis cultivation, processing, and distribution.

  • Top tenants include AWH, PharmaCann, Green Thumb, and Curaleaf, with 62% public and 87% multi-state operators.

  • Life sciences investments now represent 12.2% of base rent, with strong rent premiums and stabilizing market fundamentals.

  • Underwriting emphasizes best-in-class operators, ongoing monitoring, and financial diligence.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more